Amen Thompson gets ejected for throwing Antetokounmpo to ground by head, neck
Amen Thompson's intention was simply to stop Giannis Antetokounmpo from getting an easy dunk at the rim. How it played out, ...
pharmaphorum3h
Can Keytruda finally break into early head and neck cancer?
Keytruda has been approved since 2016 as a second-line option after chemotherapy for patients with more advanced HNSCC that ...
Looking for utter relaxation? Here are 6 of the best head spas in L.A.
Luxurious Chinese and Japanese-inspired head spa treatments are all the rage in L.A. We share favorites, and what they offer.
Everyone is losing their head over hooded snoods – and the best alternatives to a scarf and hat combo
The iconic snood may remind many of their heydays wearing a bodycon skirt from Topshop, with a Jack Wills ribbed jumper, a ...
Medscape1d
Can Radiation Dose to Tongue Mucosa Predict Taste Loss in Head, Neck Cancer?
Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...
Pharm Exec23h
FDA Grants Priority Review to Merck’s Keytruda for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...
UUHC Health Feed2d
Jason Hunt, MD, MS, FACS Named Inaugural Chair of Department of Otolaryngology – Head and Neck Surgery
Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...
manilatimes4h
Pyxis Oncology Granted FDA Fast Track Designation for PYX-201 Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer
Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...
Cure Today21h
FDA Accepts Priority Review for Pre- and Postsurgical Keytruda in HNSCC
The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...
Merck Gets Speedy FDA Review of Keytruda in Certain Head, Neck Cancers
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.